Strategies and challenges for the next generation of antibody–drug conjugates | Nature Reviews Drug Discovery
Reducing hydrophobicity of homogeneous antibody-drug conjugates improves pharmacokinetics and therapeutic index | Nature Biotechnology
Computationally designed antibody–drug conjugates self-assembled via affinity ligands | Nature Biomedical Engineering
Frontiers | The Analysis of Key Factors Related to ADCs Structural Design | Pharmacology
11 FDA Approved Antibody-Drug Conjugates: An Overview | Biochempeg
Araris Biotech
Site-selective modification strategies in antibody–drug conjugates - Chemical Society Reviews (RSC Publishing)
Unlocking the potential of antibody–drug conjugates for cancer therapy | Nature Reviews Clinical Oncology
The Clinical Landscape of Antibody-drug Conjugates » ADC Review
The clinical development of antibody–drug conjugates — lessons from leukaemia | Nature Reviews Clinical Oncology
NJ BIO — Recent Advances in ADCs
Unlocking the potential of antibody–drug conjugates for cancer therapy | Nature Reviews Clinical Oncology
Site-selective modification strategies in antibody–drug conjugates - Chemical Society Reviews (RSC Publishing)
Unlocking the potential of antibody–drug conjugates for cancer therapy | Nature Reviews Clinical Oncology
Antibody–Drug Conjugates: Perspectives and Characterization
Recent advances of antibody drug conjugates for clinical applications - ScienceDirect
World ADC Summit 2019: Bioanalysis Day summary | Bioanalysis Zone
The Role of Organic Synthesis in the Emergence and Development of Antibody–Drug Conjugates as Targeted Cancer Therapies - Nicolaou - 2019 - Angewandte Chemie International Edition - Wiley Online Library
BTG-driven conjugation: Antibodies for medicine
Frontiers | Antibody-Drug Conjugates (ADC) Against Cancer Stem-Like Cells (CSC)—Is There Still Room for Optimism? | Oncology
Antibody–drug conjugates | Nature Reviews Drug Discovery
Antibody–drug conjugates for cancer - The Lancet
